Carmustine (BCNU) in Silicone Oil Prevents Proliferation of Cultured Cells

作者: Felipe I. Tolentino , Victorio N. Cajita , Hum Chung , Norio Ueno , Miguel F. Refojo

DOI: 10.1007/978-1-4612-3910-9_23

关键词:

摘要: In proliferative vitreoretinopathy (PVR), unwanted cellular growth may occur under or over the retina following retinal detachment surgery penetrating injury to eye, and this often leads unsuccessful surgery.1 Meticulous membrane removal with adjunctive use of silicone oil for prolonged tamponade has increased surgical success rates2,3; however, PVR recur despite modality.4

参考文章(13)
H.S. Liu, H.D. Perry, M.F. Refojo, Tolerance of normal rabbit eyes to the antineoplastic carmustine. Ophthalmologica. ,vol. 181, pp. 41- 46 ,(1980) , 10.1159/000309023
Randy J. Thresher, Martin Ehrenberg, Robert Machemer, Gas-mediated vitreous compression: an experimental alternative to mechanized vitrectomy Graefes Archive for Clinical and Experimental Ophthalmology. ,vol. 221, pp. 192- 198 ,(1984) , 10.1007/BF02134139
Walter H. Stern, Geoffrey P. Lewis, Christopher J. Guerin, James J. O'Donnell, Page A. Erickson, Don H. Anderson, Steven K. Fisher, Fluorouracil Therapy for Proliferative Vitreoretinopathy after Vitrectomy American Journal of Ophthalmology. ,vol. 96, pp. 33- 42 ,(1983) , 10.1016/0002-9394(83)90452-X
Ti Li Loo, Robert L. Dion, Colorimetric Method for the Determination of 1,3-Bis(2-chloroethyl)-1-nitrosourea Journal of Pharmaceutical Sciences. ,vol. 54, pp. 809- 810 ,(1965) , 10.1002/JPS.2600540538
R H Grey, P K Leaver, Silicone oil in the treatment of massive preretinal retraction. I. Results in 105 eyes. British Journal of Ophthalmology. ,vol. 63, pp. 355- 360 ,(1979) , 10.1136/BJO.63.5.355
Daniel F. Miller, Janet W. Bay, Richard J. Lederman, Joseph D. Purvis, Lisa R. Rogers, Robert L. Tomsak, Ocular and Orbital Toxicity Following Intracarotid Injection of BCNU (Carmustine) and Cisplatinum for Malignant Gliomas Ophthalmology. ,vol. 92, pp. 402- 406 ,(1985) , 10.1016/S0161-6420(85)34036-8
Stephen J. Ryan, The pathophysiology of proliferative vitreoretinopathy in its management. American Journal of Ophthalmology. ,vol. 100, pp. 188- 193 ,(1985) , 10.1016/S0002-9394(14)75004-4
Mark S Blumenkranz, Michael K Hartzer, Anthony S Hajek, Selection of therapeutic agents for intraocular proliferative disease. II. Differing antiproliferative activity of the fluoropyrimidines. Archives of Ophthalmology. ,vol. 105, pp. 396- 399 ,(1987) , 10.1001/ARCHOPHT.1987.01060030116039